Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Atopic eczema. What has caused the epidemic in industrialised countries and can early intervention modify the natural history of atopic eczema?

Identifieur interne : 006325 ( Main/Exploration ); précédent : 006324; suivant : 006326

Atopic eczema. What has caused the epidemic in industrialised countries and can early intervention modify the natural history of atopic eczema?

Auteurs : K. Thestrup-Pedersen [Danemark, Arabie saoudite]

Source :

RBID : ISTEX:173C97CA9D54E8C22B621255C8C9789E10B5085B

English descriptors

Abstract

Atopic eczema (AE) has a lifetime prevalence of between 15 and 20% in industrialized countries, but a very low prevalence in rural Africa. The ‘atopic eczema epidemic’ has developed in industrialized countries within the last four decades. The disease has a strong genetic influence, so environmental factors must be responsible for the dramatic increase in disease prevalence. It is therefore fair to consider what interventions may change its prevalence. In this article, several factors are considered: the increased number of doctors in industrialized countries, the development of drugs like topical steroids and emollients, the ‘demanding parents’ and ‘old mother’ syndromes, introduction of vaccination programmes, allergen exposure, breastfeeding and the possible beneficial effects of probiotics. In 90% of children with AE, onset is before the age of 5. Its course runs over years. Approximately two out of three outgrow the disease between 7 and 12 years of age. Although its cause is unknown, type I allergic reactions are common and allergen avoidance has been attempted in many studies as a preventive measure in atopic dermatitis. However, results are rather disappointing. The use of probiotics, i.e. daily intake of Lactobacillus, has proven effective in preventing, or at least delaying, the development of atopic eczema. So has breastfeeding, although some studies cannot confirm its beneficial effect. Therapeutic interventions using antihistamines, desensitisation and control of skin inflammation using topical steroids have not proven successful in shortening the course of atopic eczema, although controlled studies are lacking. The use of emollients has, however, a documented effect in up to one of three children with mild atopic eczema. It will be interesting to observe if the new topical immuno‐modulators, tacrolimus and pimecrolimus, may be able to shorten the natural course of the disease.

Url:
DOI: 10.1111/j.1473-2130.2004.00086.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Atopic eczema. What has caused the epidemic in industrialised countries and can early intervention modify the natural history of atopic eczema?</title>
<author>
<name sortKey="Thestrup Edersen, K" sort="Thestrup Edersen, K" uniqKey="Thestrup Edersen K" first="K" last="Thestrup-Pedersen">K. Thestrup-Pedersen</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:173C97CA9D54E8C22B621255C8C9789E10B5085B</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1111/j.1473-2130.2004.00086.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-CC9QP1G1-P/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001D18</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001D18</idno>
<idno type="wicri:Area/Istex/Curation">001D18</idno>
<idno type="wicri:Area/Istex/Checkpoint">002328</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002328</idno>
<idno type="wicri:doubleKey">1473-2130:2003:Thestrup Edersen K:atopic:eczema:what</idno>
<idno type="wicri:Area/Main/Merge">006830</idno>
<idno type="wicri:Area/Main/Curation">006325</idno>
<idno type="wicri:Area/Main/Exploration">006325</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Atopic eczema. What has caused the epidemic in industrialised countries and can early intervention modify the natural history of atopic eczema?</title>
<author>
<name sortKey="Thestrup Edersen, K" sort="Thestrup Edersen, K" uniqKey="Thestrup Edersen K" first="K" last="Thestrup-Pedersen">K. Thestrup-Pedersen</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Department of Dermatology, Aarhus University Hospital, Aarhus</wicri:regionArea>
<wicri:noRegion>Aarhus</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Arabie saoudite</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Journal of Cosmetic Dermatology</title>
<title level="j" type="alt">JOURNAL OF COSMETIC DERMATOLOGY</title>
<idno type="ISSN">1473-2130</idno>
<idno type="eISSN">1473-2165</idno>
<imprint>
<biblScope unit="vol">2</biblScope>
<biblScope unit="issue">3‐4</biblScope>
<biblScope unit="page" from="202">202</biblScope>
<biblScope unit="page" to="210">210</biblScope>
<biblScope unit="page-count">9</biblScope>
<publisher>Blackwell Science Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2003-07">2003-07</date>
</imprint>
<idno type="ISSN">1473-2130</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1473-2130</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Adult patients</term>
<term>Allergen</term>
<term>Allergen avoidance</term>
<term>Allergy</term>
<term>Allergy clin immunol</term>
<term>Asthma</term>
<term>Atopic</term>
<term>Atopic dermatitis</term>
<term>Atopic eczema</term>
<term>Atopic eczema epidemic</term>
<term>Atopic eczema epidemicology</term>
<term>Blackwell publishing</term>
<term>Breastfeeding</term>
<term>Clin</term>
<term>Contact dermatitis</term>
<term>Cosmetic</term>
<term>Cosmetic dermatology</term>
<term>Dermatitis</term>
<term>Dermatol</term>
<term>Dermatology</term>
<term>Eczema</term>
<term>Emollient</term>
<term>Epidemicology</term>
<term>Food allergy</term>
<term>House dust mite</term>
<term>Immune</term>
<term>Immune system</term>
<term>Immunol</term>
<term>Lancet</term>
<term>Natural history</term>
<term>Older mothers</term>
<term>Pharmaceutical industry</term>
<term>Probiotic</term>
<term>Prospective study</term>
<term>Steroid</term>
<term>Tacrolimus</term>
<term>Topical</term>
<term>Topical steroids</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Atopic eczema (AE) has a lifetime prevalence of between 15 and 20% in industrialized countries, but a very low prevalence in rural Africa. The ‘atopic eczema epidemic’ has developed in industrialized countries within the last four decades. The disease has a strong genetic influence, so environmental factors must be responsible for the dramatic increase in disease prevalence. It is therefore fair to consider what interventions may change its prevalence. In this article, several factors are considered: the increased number of doctors in industrialized countries, the development of drugs like topical steroids and emollients, the ‘demanding parents’ and ‘old mother’ syndromes, introduction of vaccination programmes, allergen exposure, breastfeeding and the possible beneficial effects of probiotics. In 90% of children with AE, onset is before the age of 5. Its course runs over years. Approximately two out of three outgrow the disease between 7 and 12 years of age. Although its cause is unknown, type I allergic reactions are common and allergen avoidance has been attempted in many studies as a preventive measure in atopic dermatitis. However, results are rather disappointing. The use of probiotics, i.e. daily intake of Lactobacillus, has proven effective in preventing, or at least delaying, the development of atopic eczema. So has breastfeeding, although some studies cannot confirm its beneficial effect. Therapeutic interventions using antihistamines, desensitisation and control of skin inflammation using topical steroids have not proven successful in shortening the course of atopic eczema, although controlled studies are lacking. The use of emollients has, however, a documented effect in up to one of three children with mild atopic eczema. It will be interesting to observe if the new topical immuno‐modulators, tacrolimus and pimecrolimus, may be able to shorten the natural course of the disease.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Arabie saoudite</li>
<li>Danemark</li>
</country>
</list>
<tree>
<country name="Danemark">
<noRegion>
<name sortKey="Thestrup Edersen, K" sort="Thestrup Edersen, K" uniqKey="Thestrup Edersen K" first="K" last="Thestrup-Pedersen">K. Thestrup-Pedersen</name>
</noRegion>
</country>
<country name="Arabie saoudite">
<noRegion>
<name sortKey="Thestrup Edersen, K" sort="Thestrup Edersen, K" uniqKey="Thestrup Edersen K" first="K" last="Thestrup-Pedersen">K. Thestrup-Pedersen</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006325 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006325 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:173C97CA9D54E8C22B621255C8C9789E10B5085B
   |texte=   Atopic eczema. What has caused the epidemic in industrialised countries and can early intervention modify the natural history of atopic eczema?
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021